Print

Purpose

The purpose of this study is to evaluate safety, effiectiveness, and to gain insight into the treatment experience of participants prescribed BRIUMVI® (ublituximab-xiiy) in the real-world setting

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  1. Confirmed Multiple Sclerosis (MS) diagnosis. 2. Participants who have not received any BRIUMVI® (ublituximab-xiiy) infusion prior to study start. Participants who have been prescribed BRIUMVI® (ublituximab-xiiy) but have not yet received their first infusion on Day 1 of 150 milligrams (mg) can be included.

Exclusion Criteria

  1. Have received any live or live-attenuated vaccines (including for varicella-zoster virus or measles) within 4 weeks prior to first BRIUMVI® (ublituximab-xiiy) administration or any non-live vaccines within 2 weeks prior to first BRIUMVI® (ublituximab-xiiy) administration. 2. Any active infection (e.g., active Hepatitis B virus [HBV]) 3. Concurrent participation in any interventional MS trials, or planned concurrent treatment with other Multiple Sclerosis Disease Modifying Therapy (MS DMT) during the study period.

Study Design

Phase
Study Type
Observational
Observational Model
Case-Only
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
BRIUMVI® (Ublituximab-xiiy) Participants will receive BRIUMVI® (Ublituximab-xiiy) intravenous (IV) infusion for the treatment of RMS.
  • Other: No Intervention
    No Intervention

Recruiting Locations

TG Therapeutics Investigational Trial Site
Birmingham, Alabama 35209

TG Therapeutics Investigational Trial Site
Huntsville, Alabama 35802

TG Therapeutics Investigational Trial Site
Mobile, Alabama 36604

TG Therapeutics Investigational Trial Site
Gilbert, Arizona 85297

TG Therapeutics Investigational Trial Site
Phoenix, Arizona 85032

TG Therapeutics Investigational Trial Site
Scottsdale, Arizona 85253

TG Therapeutics Investigational Trial Site
Fresno, California 93720

TG Therapeutics Investigational Trial Site
Newport Beach, California 92663

TG Therapeutics Investigational Trial Site
Orange, California 68130

TG Therapeutics Investigational Trial Site
West Hollywood, California 90048

TG Therapeutics Investigational Trial Site
Aurora, Colorado 80045

TG Therapeutics Investigational Trial Site
Basalt, Colorado 81621

TG Therapeutics Investigational Trial Site
Colorado Springs, Colorado 80918

TG Therapeutics Investigational Trial Site
Denver, Colorado 80222

TG Therapeutics Investigational Trial Site
Fort Collins, Colorado 80528

TG Therapeutics Investigational Trial Site
Grand Junction, Colorado 81501

TG Therapeutics Investigational Trial Site
Farmington, Connecticut 06032

TG Therapeutics Investigational Trial Site
Hartford, Connecticut 06112

TG Therapeutics Investigational Trial Site
Wilmington, Delaware 19808

TG Therapeutics Investigational Trial Site
Washington D.C., District of Columbia 20010

TG Therapeutics Investigational Trial Site
Altamonte Springs, Florida 32714

TG Therapeutics Investigational Trial Site
Boca Raton, Florida 33486

TG Therapeutics Investigational Trial Site
Clearwater, Florida 33761

TG Therapeutics Investigational Trial Site
Maitland, Florida 32751

TG Therapeutics Investigational Trial Site
Miami, Florida 33176

TG Therapeutics Investigational Trial Site
Naples, Florida 34105

TG Therapeutics Investigational Trial Site
Weston, Florida 33331

TG Therapeutics Investigational Trial Site
Atlanta, Georgia 30309

TG Therapeutics Investigational Trial Site
Atlanta, Georgia 30327

TG Therapeutics Investigational Trial Site
Smyrna, Georgia 30080

TG Therapeutics Investigational Trial Site
Coeur d'Alene, Idaho 83814

TG Therapeutics Investigational Trial Site
Chicago, Illinois 60612

TG Therapeutics Investigational Trial Site
Evanston, Illinois 60201

TG Therapeutics Investigational Trial Site
Urbana, Illinois 61801

TG Therapeutics Investigational Trial Site
Lexington, Kentucky 40504

TG Therapeutics Investigational Trial Site
Louisville, Kentucky 40202

TG Therapeutics Investigational Trial Site
Baltimore, Maryland 21237

TG Therapeutics Investigational Trial Site
Glen Burnie, Maryland 21061

TG Therapeutics Investigational Trial Site
Boston, Massachusetts 02215

TG Therapeutics Investigational Trial Site
Burlington, Massachusetts 01805

TG Therapeutics Investigational Trial Site
Norfolk, Massachusetts 02481

TG Therapeutics Investigational Trial Site
Ann Arbor, Michigan 48019

TG Therapeutics Investigational Trial Site
Farmington, Michigan 48334

TG Therapeutics Investigational Trial Site
Owosso, Michigan 48867

TG Therapeutics Investigational Trial Site
Rochester Hills, Michigan 48307

TG Therapeutics Investigational Trial Site
Omaha, Nebraska 68154

TG Therapeutics Investigational Trial Site
Las Vegas, Nevada 89106

TG Therapeutics Investigational Trial Site
Bridgewater, New Jersey 08807

TG Therapeutics Investigational Trial Site
Cherry Hill, New Jersey 08002

TG Therapeutics Investigational Trial Site
Freehold, New Jersey 07728

TG Therapeutics Investigational Trial Site
Livingston, New Jersey 07039

TG Therapeutics Investigational Trial Site
Neptune City, New Jersey 00753

TG Therapeutics Investigational Trial Site
Teaneck, New Jersey 07666

TG Therapeutics Investigational Trial Site
Amherst, New York 14226

TG Therapeutics Investigational Trial Site
New York, New York 11501

TG Therapeutics Investigational Trial Site
Charlotte, North Carolina 28210

TG Therapeutics Investigational Trial Site
New Bern, North Carolina 28562

TG Therapeutics Investigational Trial Site
Raleigh, North Carolina 27607

TG Therapeutics Investigational Trial Site
Centerville, Ohio 45429

TG Therapeutics Investigational Trial Site
Centerville, Ohio 45459

TG Therapeutics Investigational Trial Site
Cincinnati, Ohio 45212

TG Therapeutics Investigational Trial Site
Cleveland, Ohio 44195

TG Therapeutics Investigational Trial Site
Columbus, Ohio 43214

TG Therapeutics Investigational Trial Site
Toledo, Ohio 43608

TG Therapeutics Investigational Trial Site
Portland, Oregon 97225

TG Therapeutics Investigational Trial Site
Bethlehem, Pennsylvania 18017

TG Therapeutics Investigational Trial Site
Knoxville, Tennessee 37996

TG Therapeutics Investigational Trial Site
Nashville, Tennessee 37215

TG Therapeutics Investigational Trial Site
Spring Hill, Tennessee 37174

TG Therapeutics Investigational Trial Site
Austin, Texas 78712

TG Therapeutics Investigational Trial Site
Austin, Texas 78723

TG Therapeutics Investigational Trial Site
Austin, Texas 78758

TG Therapeutics Investigational Trial Site
Dallas, Texas 75206

TG Therapeutics Investigational Trial Site
Edinburg, Texas 78572

TG Therapeutics Investigational Trial Site
San Antonio, Texas 78229

TG Therapeutics Investigational Trial Site
Charlottesville, Virginia 22908

TG Therapeutics Investigational Trial Site
Norfolk, Virginia 23502

TG Therapeutics Investigational Trial Site
Vienna, Virginia 22182

TG Therapeutics Investigational Trial Site
Kirkland, Washington 98034

TG Therapeutics Investigational Trial Site
Morgantown, West Virginia 26506

TG Therapeutics Investigational Trial Site
Greenfield, Wisconsin 53228

TG Therapeutics Investigational Trial Site
Milwaukee, Wisconsin 53226

TG Therapeutics Investigational Trial Site
Neenah, Wisconsin 54956

TG Therapeutics Investigational Trial Site
Waukesha, Wisconsin 53188

TG Therapeutics Investigational Trial Site
Guaynabo, Puerto Rico 00968

More Details

Status
Recruiting
Sponsor
TG Therapeutics, Inc.

Study Contact

TG Therapeutics Clinical Support Team
1-877-575-8489
clinicalsupport@tgtxinc.com

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.